Results 161 to 170 of about 45,912 (262)

Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool. [PDF]

BMJ Open, 2022
Elias Chitio JJ, Baltazar CS, Langa JP, Baloi LD, Mboane RBJ, Manuel JA, Assane S, Omar A, Manso M, Capitine I, Van Rensburg C, Luiz N, Mogasale V, Marks F, Park SE, Beck NS.   +15 more
europepmc   +1 more source

Enhancement of Manufacturing Technology for Finished Dosage Form of Bivalent Chemical Tableted Cholera Vaccine

, 2016
А. В. Комиссаров, A. Yu. Ul’yanov, О. А. Волох, И. В. Шульгина, О. А. Лобовикова, О. Д. Клокова, А. К. Никифоров   +6 more
openalex   +2 more sources

Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic Escherichia coli (ETEC) Challenge in BALB/c Mice. [PDF]

Vaccines (Basel), 2022
Hui Xian T, Parasuraman S, Ravichandran M, Prabhakaran G.   +3 more
europepmc   +1 more source

Knowledge, attitude and practice on cholera and cholera vaccine among low socio-economic group of people in urban Dhaka, Bangladesh [PDF]

, 2012
Tasnuva Wahed, Md. Jasim Uddin, Iqbal Ansary Khan, Sheikh Shah Tanvir Kaukab, Nirod Chandra Saha, Firdausi Qadri   +5 more
openalex   +1 more source

Oral cholera vaccine coverage in Goma, Democratic Republic of the Congo, 2022, following 2019-2020 targeted preventative mass campaigns. [PDF]

Vaccine X
Briskin E, Bateyi Mustafa SH, Mahamba R, Kabunga D, Kubuya J, Porten K, Epicentre-MSF DRC cholera working group, Akilimali L, Okitayemba Welo P, Broban A.   +9 more
europepmc   +1 more source

Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia. [PDF]

PLoS One, 2021
Luchen CC, Mwaba J, Ng'ombe H, Alabi PIO, Simuyandi M, Chilyabanyama ON, Hatyoka LM, Mubanga C, Bosomprah S, Chilengi R, Chisenga CC.   +10 more
europepmc   +1 more source

Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016

, 2017
Delphine Sauvageot, Christel Saussier, Abebe Gobeze, Sikhona Chipeta, Innocent Mhango, Gift Kawalazira, Martin Mengel, Dominique Legros, Philippe Cavailler, Maurice M’bang’ombe   +9 more
openalex   +1 more source

Knowledge and perception of a clinical trial among the participants: An experience from oral cholera vaccine study in Koshi Province, Nepal. [PDF]

Hum Vaccin Immunother
Chaudhary S, Uranw S, Rai B, Keshary Bhatta N, Shah GS, Poudel P, Khanal B, Shah Kalawar RP, Rai N, Shrestha J, Shrestha M, Parajuli S, Gupta BP, Vemula S, Rok Song K, Lynch J, Saluja T.   +16 more
europepmc   +1 more source

Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial. [PDF]

Lancet Infect Dis, 2021
Ali M, Qadri F, Kim DR, Islam MT, Im J, Ahmmed F, Khan AI, Zaman K, Marks F, Kim JH, Clemens JD.   +10 more
europepmc   +1 more source

Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology [PDF]

, 2017
A Bankevich, A Mentzer von, A Sjoling, AC Vicente, AM Almeida de, AR Quinlan, AR Wattam, C Lindenthal, CA Jacobi, D Hernandez, DA Rasko, DA Rasko, DG Evans, DJ Ingle, EW Myers, F Canto Del, F Canto Del, F Qadri, GB Lindblom, GP Munson, H Steinsland, HL DuPont, HL DuPont, I Bolin, I Letunic, JM Fleckenstein, JM Fleckenstein, JM Fleckenstein, JS Farris, JW Sahl, JW Sahl, JW Sahl, JW Sahl, JW Sahl, K Hayashi, K Roy, K Roy, K Roy, K Schliep, KL Kotloff, LC Crossman, M So, M So, MA Lasaro, MN Price, MS Donnenberg, P Kumar, Q Luo, R Lozano, RA Finkelstein, RA Nada, RB Sack, RC Edgar, RI Walker, S Schubert, SF Altschul, SK Patel, SM Turner, T Seemann, T Wirth, TH Hazen, W Gaastra, WHO   +62 more
core   +2 more sources